Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Nykode Therapeutics - Share capital increase from exercise of warrants

Nykode Therapeutics
Oslo, Norway, November 10, 2023 - As a consequence of exercise of 531,802
warrants in Nykode Therapeutics ASA with expiry date December 31, 2023, the
share capital of Nykode Therapeutics ASA has increased by NOK 5,318.02 from NOK
3,250,437.09 to NOK 3,255,755.11. The number of outstanding shares in the
company has increased by 531,802 from 325,043,709 to 325,575,511, each with a
par value of NOK 0.01. The warrants were exercised by employees, where 133,335
warrants were exercised at a subscription price of NOK 7.0 per share and 398,467
warrants were exercised at a subscription price of NOK 9.4 per share.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team